European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties meeting with all eligible organisations - 2025

• Date:
  tisdag, 18 november 2025 , 09:00 - 17:30 Amsterdam time (CET)
• Plats:
  Online
  European Medicines Agency, Amsterdam, the Netherlands

Event summary

The two-day meeting brings together all eligible patient, consumer and healthcare professionals organisations and members of the Patients' and Consumers' Working Party (PCWP) and Healthcare Professionals' Working Party (HCPWP).

The meeting focuses on the following topics:

• Update on new pharmaceutical legislation 
• Clinical Trials updates
• Real-World Evidence
• Availability and supply of medicines
• Gender equality and women's health
• Product information updates
• Communication and outreach activities
• Members’ voice

Documents

Agenda - PCWP/HCPWP and all eligible organisations meeting 2025

Draft Reference Number: EMA/271255/2025

Meeting summary - PCWP/HCPWP and all eligible organisations meeting 18 November 2025

Reference Number: EMA/364256/2025

Presentations

Presentation - Patient and HCP engagement highlights 2025 (M. Carr)

Presentation - Overview of evolution of patient and healthcare professional engagement in EMA activities (M. Mavris)

Presentation - EMA-led RWE generation (D. Morales)

Presentation - Updates on Cancer Medicines Forum (C. Voltz-Girolt)

Presentation - Multi-stakeholder platform 2025 activity (D. Lacombe, F. Houÿez, A. Zanoletty)

Presentation - Accelerating Clinical Trials in the EU (ACT EU) (L. Pioppo)

Presentation - A Patient’s quest to the Magical Land of Clinical Trials: Is there a Yellow Brick Road? (I. Psalti)

Presentation - Annual training 2026 (K. Immonen)

Presentation - Training on Scientific Advice (L. Barbier)

Presentation - EMA international engagement and activities (M. Harvey)

Presentation - Updates from the Cardiovascular Space (M. Holler)

Presentation - Aligning policies with real-world medical needs (M. Romano)

Presentation - Proposed Critical Medicines Act (V. Bennett)

Presentation - Introducing to shortages topic (M. Dias)

Presentation - Union list of critical medicines - first annual update (S. McMahon)

Presentation - Shortage Prevention Plan and Shortage Mitigation Plan pilot (M. Alcaraz)

Presentation - Ongoing critical shortages and activities (K. Kruttwig)

Presentation - EAHP Survey on the shortages of medicines and medical devices (D. Makridaki)

Presentation - Update on QRD template revision and ‘Key information section’ (KIS) survey (M. Buch)

Presentation - EMA-HMA repurposing pilot report (C. Bouygues)

Presentation - Social media campaigns (G. Gabrielli)

Presentation - Communications on safety monitoring of medicines in the EU (V. Pashova, S. Cohen)

Presentation - Gender equality in women’s health - the forgotten priority (C. de Vries)

Presentation - Medicine overviews - Feedback from patient and healthcare professional survey (C. Ester)

Presentation - Update on Human Medicines Highlights (K. Immonen)